First human totally endoscopic aortic valve replacements reported

This graphic shows the procedural steps of the sutureless bioprosthesis. A, Sutureless bioprosthesis ready for compression. B, Compressed valve ready to be inserted in the trocar. C, Sutureless bioprosthesis passage through the main operative 20-mm trocar. D, Sutureless bioprosthesis compressed and inserted into the aortic root after removal of the native aortic valve. E, Sutureless bioprosthesis, endoscopic decompression, and adjustment into the aortic annulus. F, Complete expansion of the sutureless valve into the aortic root. Credit: American Association for Thoracic Surgery

Surgeons in France have successfully replaced the aortic valve in two patients without opening the chest during surgery. The procedure, using totally endoscopic aortic valve replacement (TEAVR), shows potential for improving quality of life of heart patients by offering significantly reduced chest trauma. It is described in the Journal of Thoracic and Cardiovascular Surgery, an official publication of the American Association for Thoracic Surgery.

Endoscopic surgery is already used by cardiovascular surgeons for procedures such as atrial septal defect repair and . This leads to faster recovery time and less pain, which improves patients' quality of life.

TEAVR had not been feasible previously because of the currently available designs of stented tissue valves. The recent advent of sutureless bioprostheses mounted on a compressible self-expanding nitinol (nickel titanium) stent, was one of the key factors enabling the surgical team to perform this procedure. Implantation required less than 45 minutes in either patient. Sutureless substitutes are not yet available for the other cardiac valves, like the mitral valve.

"In our institution, we began by adopting the mini-sternotomy technique, involving a small incision through the sternum, as routine. We then transitioned to the right mini-thoracotomy approach, involving a small incision through the thorax, first under direct view, then with an endoscopic camera. Finally we adopted a totally endoscopic technique," explains lead author Marco Vola, MD, PhD, of the Department of Cardiovascular Surgery, Centre Hospitalier Universitaire de Saint-Etienne, France.

"It is important to note that when performing TEAVR, a quick and safe conversion to mini-thoracotomy under direct view can be made if circumstances demand. This would still offer significantly reduced ," he adds.

This image shows the skin aspect three months after TEAVR surgery. Credit: American Association for Thoracic Surgery

In other fields, totally involved longer clamping and cardiopulmonary bypass (CPB) times during the learning curve. The investigators believe that clamping and CPB times were acceptable and that the learning curve could be shorter than reported for totally endoscopic grafting.

Enhancements such as endoscopic sizers, dedicated instruments for decalcification, and second-generation sutureless bioprostheses to simplify implantation, could improve the procedure further, Dr. Vola and his colleagues comment. Last but not least, surgical robots may offer additional benefits.

"These first procedures show that totally endoscopic sutureless is technically feasible. Further clinical experience and technical development are necessary to shorten operation times and to assess further the potential postoperative benefits of TEAVR," concludes Vola.

More information: "First human totally endoscopic aortic valve replacement: An early report," by Marco Vola, MD, PhD; Jean-François Fuzellier, MD; Bertrand Chavent, MD; and Ambroise Duprey, MD (DOI: dx.doi.org/10.1016/j.jtcvs.2013.10.010). The Journal of Thoracic and Cardiovascular Surgery, Volume 147, Issue 3 (March 2014)

Provided by American Association for Thoracic Surgery

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

TAVI is safe alternative to redo cardiac surgery

Sep 02, 2013

TAVI is a safe alternative to redo cardiac surgery for failing bioprosthetic valves, according to research presented at the ESC Congress today by Dr. Spyridon Katsanos from the Netherlands. The findings suggest that transcatheter ...

Recommended for you

Results of RIBS IV trial reported

9 hours ago

A new clinical trial comparing the use of everolimus-eluting stents (EES) and drug-eluting balloons (DEB) in treating in-stent restenosis (ISR) from drug-eluting stents found that EES provided superior late angiographic results ...

Results of DKCRUSH-VI trial reported

9 hours ago

A new study found that fractional flow reserve (FFR)-guided provisional side branch (SB) stenting of true coronary bifurcation lesions yields similar outcomes to the current standard of care. The DKCRUSH-VI clinical trial ...

Results of IVUS-CTO trial reported at TCT 2014

9 hours ago

A new study found that intravascular ultrasound (IVUS) -guided intervention in patients with chronic total occlusion (CTO) could improve outcomes compared to a conventional angiography-guided approach during percutaneous ...

Results of OCT STEMI trial reported at TCT 2014

9 hours ago

The first randomized trial to examine serial optical coherence tomography (OCT) in primary percutaneous coronary intervention (PCI) was reported at the 26th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific ...

INR variability predicts warfarin adverse effects

15 hours ago

(HealthDay)—Unstable anticoagulation predicts warfarin adverse effects regardless of time in therapeutic range, according to a study published online Sept. 2 in Circulation: Cardiovascular Quality and Ou ...

User comments